Neumann Mark

CIK 00017562111 companyBEDMINSTER, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001756211

Recent Transactions

50 trades

Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−13,133→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−17,916→ 0 total
Award
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02+13,134→ 13,134 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−22,727→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02−13,134→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−17,485→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02−8,742→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Common Stock
2025-04-02$132.00/sh−52,811→ 0 total
Award
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02+8,742→ 8,742 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-10$131.24/sh−3,116→ 52,811 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-10−7,345→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-10+7,345→ 55,927 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-06$131.19/sh−5,572→ 48,582 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-06−13,133→ 13,133 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-06+13,133→ 54,154 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-01−8,742→ 17,485 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-01+8,742→ 44,730 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-01$128.20/sh−3,709→ 41,021 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-02-03+22,727→ 22,727 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2025-01-31+11,017→ 40,717 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-01-31$127.00/sh−4,729→ 35,988 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-08-16$36.89/sh+18,714→ 48,414 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-08-16−18,714→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-08-16$75.08/sh−18,714→ 29,700 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$66.86/sh−1,313→ 29,700 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$65.11/sh−4,303→ 32,742 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$65.92/sh−1,729→ 31,013 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-10−7,345→ 7,345 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-10+7,345→ 37,045 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-07$66.37/sh−8,636→ 34,196 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-07$66.95/sh−4,496→ 29,700 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-06+13,132→ 42,832 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-06−13,132→ 26,266 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-01+26,227→ 26,227 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$71.18/sh−1,307→ 29,700 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$70.70/sh−2,341→ 31,007 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$69.56/sh−4,059→ 33,348 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$68.03/sh−200→ 37,407 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-02-23−7,907→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-23+7,907→ 37,607 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-02$66.67/sh−4,956→ 36,604 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-02$67.49/sh−6,904→ 29,700 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-01+11,860→ 41,560 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-11-06$55.02/sh−15,639→ 29,700 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-11-06$55.98/sh−26,754→ 45,339 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2023-11-06$23.94/sh+26,754→ 72,093 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2023-11-06−26,754→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2023-08-07$18.59/sh+55,300→ 100,639 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-08-07$58.79/sh−55,300→ 45,339 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2023-08-07−55,300→ 0 total

Companies

Intra-Cellular Therapies, Inc.
EVP, Chief Commercial Officer

Recent Filings

Address

C/O INTRA-CELLULAR THERAPIES, INC. 135 ROUTE 202/206, SUITE 6

BEDMINSTER, NJ, 07921

View on SEC.gov